Yahuilong Clarifies Strategic Collaboration with Neurastar: Non-Invasive BCI Approach Distinct from Neuralink

NBD AI Flash: January 6,Yahuilong(688575.SH) issued a supplementary announcement on voluntary disclosure regarding the signing of a strategic cooperation framework agreement, stating that Brain-Computer Starlink has been established for a short period and is relatively small in scale. Currently, its main products under development in the sleep product segment include EEG acquisition and analysis devices, brain-computer interface (BCI) sleep aid devices, BCI sleep monitoring devices, and vagus nerve stimulators. The related products have not yet entered the registration application stage; among them, the vagus nerve stimulator is in the preparation stage for testing required for Class II medical device certificate registration. Products in the fields of Alzheimer’s disease, autism, and stroke diagnosis are currently in the early R&D or preclinical stages. The technical route of Brain-Computer Starlink’s products under development is non-invasive, which is fundamentally different from the technical approach adopted by Neuralink, the brain-computer interface company founded by Elon Musk. Currently, there is no layout for invasive technology.